Changes are being made to a federal autism panel, with some outlets reporting that the overhaul is being done in the image of its leader. However, the nature and implications of these changes are unclear, with some reports suggesting that promoters of disputed vaccine-autism claims are being appointed to key roles. The move has sparked attention amidst broader discussions on rethinking autism research.